Home » Topics » Conferences

Conferences
RSS

Novartis pursues development of Src kinase inhibitors for osteoporosis

Oct. 6, 1999

rhPM-1 inhibits synovial cell proliferation in vitro, inflammatory cell infiltration in vivo

Oct. 5, 1999

Bacterial efflux pump inhibitors developed at Microcide and presented at ICAAC meeting

Oct. 5, 1999

New class of oxazolidinones with broader spectrum presented at ICAAC by Pharmacia & Upjohn

Oct. 5, 1999

Lipopeptide synthesized at Abbott may be therapeutically useful antifungal agent

Oct. 5, 1999

Potent phenylisoxazoline antimicrobial agents designed at Pharmacia & Upjohn

Oct. 5, 1999

Lilly and Synaptic investigate potential of 5-HT1A antagonist in nicotine withdrawal

Oct. 5, 1999

SUN-N4057 reduces both brain and body temperature in cat model of stroke

Oct. 5, 1999

Adenosine-dependent cardioprotective effect demonstrated for MX-68

Oct. 5, 1999

SmithKline Beecham reports advances in vitronectin receptor antagonist research

Oct. 5, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...